India emphasised the need to increase the number of inspections by the US Food and Drug Administration  FDA  in India to facilitate trade and continue to reduce the backlog.India emphasised the need to increase the number of inspections by the US Food and Drug Administration  FDA  in India to facilitate trade and continue to reduce the backlog. The US appreciated India s remarks, noting that the FDA has increased staffing to increase pharmaceutical inspections conducted by the agency.
India requested increased FDA inspections to expedite trade and reduce the backlog. The US acknowledged the request and stated that the FDA has increased staffing to conduct more pharmaceutical inspections.